Ascelia Pharma AB
F:7ZA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascelia Pharma AB
F:7ZA
|
SE |
|
M
|
Matachewan Consolidated Mines Ltd
OTC:MWCAF
|
CA |
|
1-800-Flowers.Com Inc
NASDAQ:FLWS
|
US |
|
Mitsuboshi Co Ltd
TSE:5820
|
JP |
|
Iktinos Hellas Greek Marble Industry SA
LSE:0OMO
|
GR |
|
DyDo Group Holdings Inc
TSE:2590
|
JP |
|
Orient Corp
TSE:8585
|
JP |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
|
Wize Inc
TSE:3664
|
JP |
|
T
|
Touchstone International Medical Science Co Ltd
SSE:688013
|
CN |
|
Ev Dynamics Holdings Ltd
HKEX:476
|
HK |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
C
|
CEZ as
XMUN:CEZ
|
CZ |
|
K
|
KBI Dongkook Ind Co Ltd
KRX:001620
|
KR |
|
Palace Capital PLC
LSE:PCA
|
UK |
|
S
|
Samil Enterprise Co Ltd
KOSDAQ:002290
|
KR |
|
Flight Centre Travel Group Ltd
ASX:FLT
|
AU |
|
JejuAir Co Ltd
KRX:089590
|
KR |
|
Bang Holdings Corp
OTC:BXNG
|
US |
|
G
|
Gildan Activewear Inc
F:VGA
|
CA |
|
Westbury Bancorp Inc
OTC:WBBW
|
US |
|
Coastal Carolina Bancshares Inc
OTC:CCNB
|
US |
|
D
|
Denison Mines Corp
F:IUQ
|
CA |
|
S
|
Stars Microelectronics Thailand PCL
SET:SMT
|
TH |
Bankruptcy Probability
Ascelia Pharma AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ascelia Pharma AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Ascelia Pharma AB
STO:ACE
|
79.3m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ascelia Pharma AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ascelia Pharma AB has total debt of 31k SEK. This includes both short-term (0 SEK) and long-term (31k SEK) debt.
You can find a full breakdown on its Balance Sheet.